MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Utility and safety of same day discharge after Deep Brain Stimulator Electrode Implantation: a feasibility study

    S. Pardakhtim, M. Marsans, S. Srivastal, J. Roberts, F. Farrokhi (Seattle, USA)

    Objective: The purpose of this study is to determine the demographics and characteristics of patients diagnosed with Parkinson’s Disease or Essential Tremor who can be…
  • 2023 International Congress

    Non-intrusive Video-Based Solution for Continuous Quantitative Monitoring of Parkinson’s Patients’ Motor Functions

    A-S. Bridoux, G. Altares, G. Garraux, M. Koivu, L. Mäkitie, E. Fiorenzato, L. Weis, A. Antonini, A. Nieuwboer (Mons, Belgium)

    Objective: Feasibility and preliminary validation of a marker-less solution for automatic capture and quantification of movements during prespecified tasks of people with Parkinson’s (PwP) using…
  • 2023 International Congress

    Make-up for Parkinson’s: a randomized control trial

    M. Darabseh, A. Aburub (Amman, Jordan)

    Objective: To assess the effectiveness of using “applying make-up" as a physiotherapy and occupational therapy intervention to reduce bradykinesia in people with Parkinson’s. Background: People…
  • 2023 International Congress

    Incidence of Parkinson’s disease and modifiable risk factors in Korean population: A longitudinal follow-up study of a nationwide cohort

    SJ. Chung, SH. Kang, S-J. Moon, M. Kang, GJ. Cho, S-B. Koh (Goyang, Republic of Korea)

    Objective: We aimed to investigate the incidence of Parkinson’s disease (PD) by age and year for each sex as well as the modifiable risk factors…
  • 2023 International Congress

    A staged screening paradigm to identify people at risk of Parkinson’s disease in the Parkinson’s Progression Markers Initiative

    E. Brown, A. Siderowf, T. Simuni, T. Sherer, M. Brumm, C. Caspell-Garcia, R. Kurth, C. Gochanour, M. Kuhl, M. Korell, J. Valverde Twiggs, C. Stanley, L. Concha, C. Soto, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To identify people at risk of Parkinson’s disease (PD) using a staged-screening paradigm. Background: Early recognition of people with PD may be essential to…
  • 2023 International Congress

    Risk of Parkinson’s Disease due to Helicobacter Pylori and High Salt Consumption

    V. Balendra (Park Ridge, USA)

    Objective: The association between excessive salt consumption, susceptibility to H. pylori infection and risk of Parkinson's disease will be analyzed through scientific studies. Background: The…
  • 2023 International Congress

    Assessment of non-motor symptoms of Parkinson’s disease after the repeated courses of the autologous stem cell therapy

    V. Chyzhyk, A. Boika, V. Ponomarev (Minsk, Belarus)

    Objective: To evaluate the influence of the second course of the cell therapy on the dynamics of the non-motor symptoms in patients with PD 6…
  • 2023 International Congress

    The mGlu2 positive allosteric modulator AZD8529 alleviates L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmoset

    J. Shaqfah, I. Frouni, C. Kwan, D. Bédard, S. Nuara, J. Gourdon, A. Hamadjida, P. Huot (Montreal, Canada)

    Objective: To assess the effect of the metabotropic glutamate 2 (mGlu2) receptor positive allosteric modulator (PAM) AZD8529 on L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia and psychosis-like behaviours (PLBs)…
  • 2023 International Congress

    Strategic decision-making in Parkinson’s disease with fatigue

    C. Pauletti, D. Mannarelli, F. Milano, A. Maffucci, A. Petritis, F. Fattapposta (Rome, Italy)

    Objective: To assess response inhibition and strategic decision-making abilities associated with fatigue in Parkinson’s disease (PD). Background: PD-related fatigue is defined as a feeling of…
  • 2023 International Congress

    Effect of dietary caffeine on brain dopamine transporter binding in Parkinson’s disease

    E. Saarinen, T. Kuusimäki, K. Lindholm, EA. Honkanen, T. Noponen, M. Seppänen, K. Murtomäki, T. Mertsalmi, E. Jaakkola, E. Mäkinen, M. Eklund, S. Nuuttila, R. Levo, KR. Chaudhuri, A. Antonini, J. Joutsa, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: To investigate the relationship between dietary caffeine intake and striatal dopamine function over the progression of Parkinson’s disease (PD). Background: The association between high…
  • « Previous Page
  • 1
  • …
  • 227
  • 228
  • 229
  • 230
  • 231
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley